Virtual Medicinal Product (VMP) - Bupivacaine 12.5mg/5ml (0.25%) / Adrenaline (base) 25micrograms/5ml (1 in 200,000) solution for injection ampoules

Navigation

Name Details

Name Start Date End Date
Name Current Name Bupivacaine 12.5mg/5ml (0.25%) / Adrenaline (base) 25micrograms/5ml (1 in 200,000) solution for injection ampoules Start Date 01-07-2014 End Date
Previous Name Previous Name Bupivacaine 12.5mg/5ml (0.25%) / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules Start Date 09-10-2007 End Date 30-06-2014
Abbreviated Name Abbreviated Name Bupivacaine 12.5mg/Adrenaline (base) 25microg/5ml inj amp Start Date 17-03-2015
Previous Abbreviated Name Bupivacaine 12.5mg/5ml/Adrenaline 25microg/5ml inj amp Previous Start Date 27-03-2009 Previous End Date 16-03-2015

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
5
UDFS UOM
ml
Unit Dose UOM
ampoule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Epidural
Form
Solution for injection
Ontology Form/Route
solutioninjection.epidural
Name Basis
Other

Codes

ATC Code
N01BB51
SNOMED Codes
Code Start Date End Date
10188011000001100 16-03-2006
353273003 09-03-2006 15-03-2006

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Adrenaline acid tartrate Based on Base Substance Adrenaline 5 microgram 1 ml
Bupivacaine hydrochloride anhydrous Based on Ingredient Substance 2.5 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 ampoule